| Wegovy pill | Foundayo | |
|---|---|---|
| Drug | Oral semaglutide | Orforglipron (small-molecule GLP-1) |
| US launch | January 2026 | April 2026 |
| How to take | Once daily, empty stomach, small sip of water, wait 30 minutes before eating | Once daily, no food or water restrictions |
| Average weight loss in trials | ~14% (~17% in people who stayed on it) | ~12% at top dose |
| Cash price | ~$149–$299/mo by dose | From $149/mo |
| Where to get it | NovoCare, Ro, Hims & Hers, GoodRx, WW, retail pharmacies | LillyDirect, Ro, GoodRx and others |
Pill or injection?
Injections still produce somewhat more weight loss on average. Pills suit people who dislike needles or want a cheaper starting option. Foundayo is easier to take; the Wegovy pill produced slightly more weight loss in trials.
Compare providers that offer GLP-1 pills →
GLP1Rated is for general information only and is not medical advice. GLP-1 medications are prescription drugs with real risks and side effects. Talk to a licensed clinician before starting, stopping or changing any medication or supplement.